HTT p.Gln38Pro
c.113A>C · VCV3910363
Computational evidence
| Protein change | ||
| AlphaMissense | 0.0772 | likely benign |
|---|---|---|
| REVEL | 0.026 | moderately benign-leaning |
| SaProt | — | not scored · why |
| ⇒ AlphaMissense and REVEL both call this tolerated; SaProt makes no call. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP -0.23 | GERP 0.045 |
| Overall | ||
| CADD | 9.647 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL is an independent agreement signal.
⚠ Isoform check: AlphaMissense numbered on a different transcript (AM Q36P vs ClinVar Q38P) — verify the residue.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| Finnishnot grpmax-eligible | 23.7% | 4 |
| East Asiangrpmax | 22.5% | 4 |
| African / African-American | 18.5% | 5 |
| Amishnot grpmax-eligible | 15.6% | 6 |
| Admixed American | 12.4% | 8 |
| Remaining individualsnot grpmax-eligible | 8.39% | 12 |
| South Asian | 8.06% | 12 |
| Ashkenazi Jewishnot grpmax-eligible | 6.94% | 14 |
| Middle Eastern | 5.24% | 19 |
| European (non-Finnish) | 4.74% | 21 |
Finnish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- HTT
- Protein
- p.Gln38Pro
- Coding
- c.113A>C
- MANE Select
- NM_001045 · reported on NM_002111
- Type
- single nucleotide variant
- Location
- chr4:3074932 (GRCh38)
- Structure
- AlphaFold pLDDT 85.38 · 30 PDB
- Residue 38
- the 'disordered' region
Similar variants
- HTT p.Gln38_Pro39insGln Benign ★★ same residue
- HTT p.Gln38_Pro39insGlnGlnGlnGlnGln Likely benign ★★ same residue
- HTT p.Gln38_Pro39insGlnGlnGlnGlnGlnGlnGlnGlnGln Likely benign ★★ same residue
- HTT p.Gln38_Pro39insGlnGlnGlnGlnGlnGlnGlnGlnGlnGlnGlnGln Benign/Likely benign ★★ same residue
- HTT p.Gln38_Pro39insGlnGlnGlnGlnGlnGlnGlnGlnGlnGln Conflicting classifications of pathogenicity ★ same residue
- HTT p.Gln38_Pro39insGlnGlnGlnGln Likely benign ★ same residue
- HTT p.Gln38_Pro39insGlnGlnGlnGlnGlnGlnGlnGlnGlnGlnGln Likely benign ★ same residue
- HTT p.Gln38_Pro39insGlnGlnGlnGlnGlnGlnGlnGlnGlnGlnGlnGlnGln Likely benign ★ same residue
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/htt-p-gln38pro (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown